Bornholms Regionskommune Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2020
NCT04601116
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Bornholms Hospital | Bornholms Regionskommune

Active Ingredients

Drugs in Phase 3 Trials (1)

atorvastatin (lipitor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1